Phase 2 Mild Cognitive Impairment (MCI) Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
Alzheimer DiseaseMild Cognitive Impairment (MCI)Subjective Cognitive Complaints (SCCs)
Massachusetts General Hospital40 enrolled1 locationNCT07236190
Recruiting
Phase 2
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
Mild Cognitive Impairment (MCI)Cognitive Training
Columbia University240 enrolled4 locationsNCT06601933
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd114 enrolled8 locationsNCT07027072
Recruiting
Phase 2
Multi-session Transcranial Alternating Current Stimulation to Improve Dual-task Standing and Brain Activity in Older Adults With Mild Cognitive Impairment
Mild Cognitive Impairment (MCI)
High Point University20 enrolled1 locationNCT07097051